✦ LIBER ✦

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617

✍ Scribed by Thomas R Chauncey; Cathryn Rankin; Jeanne E Anderson; I-Ming Chen; Kenneth J Kopecky; John E Godwin; Matt E Kalaycio; Dennis F Moore Jr; Muhammad S Shurafa; Stephen H Petersdorf; Eric H Kraut; Catherine P Leith; David R Head; Frederick W Luthardt; Cheryl L Willman; Frederick R Appelbaum

Book ID: 114118853
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 83 KB
Volume: 24
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(00)00024-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of two schedules of low

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

✍ Sergio Amadori; Stefan Suciu; Dominik Selleslag; Roberto Stasi; Giuliana Alimena 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB